We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$70.1B
AUM Growth
-$3.23B
Cap. Flow
-$4.59B
Cap. Flow %
-6.55%
Top 10 Hldgs %
10.04%
Holding
5,020
New
596
Increased
1,359
Reduced
1,925
Closed
795

Sector Composition

Rank Sector Weight
1 Communication Services 9.11%
2 Healthcare 7.95%
3 Consumer Discretionary 7.93%
4 Financials 7.4%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCMP
4151
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$96K ﹤0.01%
13,482
-71,759
-84% -$614K
UNXL
4152
CALL
DELISTED
Uni-Pixel, Inc.
UNXL
$95K ﹤0.01%
12,400
-36,500
-75% -$348K
ARIA
4153
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$93K ﹤0.01%
11,500
-100,300
-90% -$781K
IMH
4154
DELISTED
Impac Mortgage Holdings Inc.
IMH
$86K ﹤0.01%
14,353
-9,833
-41% -$64.3K
MERC icon
4155
CALL
Mercer International
MERC
$44.9M
$85K ﹤0.01%
11,300
RIC
4156
DELISTED
Richmont Mines Inc.
RIC
$85K ﹤0.01%
60,595
-266,707
-81% -$405K
AVNR
4157
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$83K ﹤0.01%
22,646
-76,891
-77% -$293K
ERII icon
4158
Energy Recovery
ERII
$434M
$81K ﹤0.01%
+15,153
New +$74.6K
BUSE icon
4159
First Busey Corp
BUSE
$2.52B
$78K ﹤0.01%
4,499
-6,488
-59% -$113K
MTBL
4160
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$75K ﹤0.01%
+15,333
New +$79K
INVE icon
4161
Identive
INVE
$64.6M
$74K ﹤0.01%
6,530
-1,270
-16% -$11.3K
APP
4162
DELISTED
AMERICAN APPAREL INC COM
APP
$74K ﹤0.01%
146,808
+110,043
+299% +$99.8K
CACH
4163
DELISTED
CACHE INC (DE)
CACH
$74K ﹤0.01%
22,400
VVTV
4164
DELISTED
VALUEVISION MEDIA INC
VVTV
$71K ﹤0.01%
14,520
-14,746
-50% -$86.8K
GEVO icon
4165
Gevo
GEVO
$397M
$70K ﹤0.01%
10
-4
-29% -$31.6K
CRIS icon
4166
Curis
CRIS
$9.53M
$66K ﹤0.01%
12
-5
-29% -$30K
LXRX icon
4167
Lexicon Pharmaceuticals
LXRX
$1.02B
$66K ﹤0.01%
5,472
-39,926
-88% -$510K
HNSN
4168
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$64K ﹤0.01%
2,481
-9,634
-80% -$216K
VTG
4169
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$64K ﹤0.01%
37,272
-11,900
-24% -$20.7K
ACLS icon
4170
Axcelis
ACLS
$4.12B
$62K ﹤0.01%
7,192
-16,538
-70% -$152K
IMMU
4171
DELISTED
Immunomedics Inc
IMMU
$60K ﹤0.01%
+14,300
New +$70.9K
END
4172
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
$59K ﹤0.01%
18,031
-143,028
-89% -$742K
TLRA
4173
DELISTED
Telaria, Inc.
TLRA
$58K ﹤0.01%
14,192
-700
-5% -$3.21K
AMD icon
4174
CALL
Advanced Micro Devices
AMD
$851B
$55K ﹤0.01%
+13,600
New +$51.9K
MRGE
4175
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$55K ﹤0.01%
22,732
+7,566
+50% +$18K

Similar funds

D.E. Shaw & Co's Q1 2014 Portfolio in Review

As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.1% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in Veren worth $53.3M.

  • D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
  • D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
  • D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
  • D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.

Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.